-
SM-102: From LNP Mechanism to Translational Strategy
2026-08-19
A translational perspective on SM-102, connecting ionizable-lipid function, mRNA delivery, formulation controls, and localized oncology applications while distinguishing platform evidence from product-specific validation.
-
LY2109761 Workflows for TGF-β Signaling
2026-08-19
LY2109761 provides a practical way to interrogate receptor-proximal TGF-β signaling in cancer, fibrosis, and radiation-response models. This guide connects Smad2/3 phosphoprotein assays with functional workflows, reference-study insights, and troubleshooting strategies for more reproducible pathway experiments.
-
Aneugen Molecular Mechanism Assay: 27-Chemical Study
2026-08-18
Bernacki and colleagues developed a tiered flow-cytometric strategy that distinguishes tubulin stabilization, tubulin destabilization, and mitotic kinase inhibition among aneugenic chemicals. Its combination of biomarker profiling, Taxol-associated fluorescence, and machine learning improved mechanistic interpretation beyond a simple positive or negative genotoxicity result.
-
Sulfo-Cy5 in Translational Mucosal Research
2026-08-18
How Sulfo-Cy5 carboxylic acid can help translational researchers connect nanoparticle distribution, intestinal targeting, and immune-function readouts without confusing fluorescent tracking with biological efficacy.
-
Plerixafor (AMD3100): A Trafficking Assay Guide
2026-08-17
Plerixafor (AMD3100) is more than a CXCR4 inhibitor: it is a mechanistic probe for studying cellular trafficking, tumor-associated platelet extravasation, and hematopoietic stem cell mobilization. This guide connects receptor pharmacology with assay selection, interpretation, and experimental controls.
-
Mechanical Stress, Cytoskeleton, and Autophagy
2026-08-17
Liu et al. provide direct evidence that the cytoskeleton, especially actin microfilaments, is required for autophagy induced by compressive mechanical stress. Their combined use of cytoskeletal perturbation, fluorescence imaging, and western blotting offers a practical framework for separating core mechanotransduction structures from auxiliary components.
-
L1023 Anti-Cancer Compound Library for ccRCC
2026-08-16
PLAC1 has emerged as a prognostic biomarker and molecular target in clear cell renal cell carcinoma. This thought-leadership guide shows how researchers can translate that finding into biomarker-aware screening and validation using the DiscoveryProbe™ Anti-cancer Compound Library (SKU: L1023), while distinguishing mechanistic evidence from actionable workflow recommendations.
-
JSH-23: A Practical NF-κB Inhibitor Workflow
2026-08-15
JSH-23 gives researchers a mechanistically focused way to separate NF-κB p65 nuclear transcription from upstream IκB turnover. This guide translates that distinction into cell-based inflammation assays, cytokine studies, and cautious disease-model validation.
-
MDL 28170: A Selective Calpain Inhibitor
2026-08-14
MDL 28170 combines cell permeability, blood-brain barrier access, and dual calpain/cathepsin B inhibition for mechanistic studies of neuronal injury, apoptosis, and protease-driven cytotoxicity. This guide translates recent hippocampal findings into practical workflows while distinguishing validated evidence from optimization starting points.
-
FPR2/ALX Signaling in Autoimmune Astrocytopathy
2026-08-14
The reference study identifies FPR2/ALX stimulation by Quin-C1 as an immunomodulatory strategy that limits AQP4-IgG- and complement-driven autoimmune astrocytopathy in mice. Its depletion and pathway-inhibition experiments implicate microglia, natural killer cells, and SYK-AKT signaling in the protective response, while also highlighting the need for validation beyond the animal model.
-
Nitrocefin: From β-Lactamase Signal to Translation
2026-08-13
Nitrocefin converts β-lactamase hydrolysis into a rapid yellow-to-red signal, giving translational researchers a practical bridge between enzyme mechanism, resistance profiling, inhibitor discovery, and computational peptide screening. This article outlines how to interpret the assay beyond a simple color change and how to position it within a rigorous development workflow.
-
Decitabine Primes Progenitor Tex for PD-1 Blockade
2026-08-13
A 2023 Journal of Clinical Investigation study shows that low-dose decitabine can improve anti–PD-1 therapy by expanding CD8+ progenitor exhausted T cells rather than merely reactivating terminally exhausted cells. The work identifies sustained JunD and JNK/AP-1 activity as an important mechanistic link and offers a framework for evaluating epigenetic priming in tumor-immunology models.
-
Dextrose Workflows for Hypoxic Tumor Research
2026-08-12
Build controlled hypoxia–nutrient experiments with Dextrose (D-glucose), from fresh stock preparation to immune–tumor co-culture readouts. This workflow emphasizes matched controls, practical concentration matrices, and troubleshooting strategies that distinguish glucose effects from oxygen, osmotic, and handling artifacts.
-
Angiotensin (1-7): Applied Research Workflows
2026-08-12
Build reproducible Mas-receptor, fibrosis, inflammation, metabolic, and peptide–receptor-binding assays around a high-purity endogenous heptapeptide. This guide connects literature-backed benchmarks with practical stock preparation, dose selection, assay controls, and troubleshooting for translational research.
-
Dihydrotestosterone: From AR Trigger to Assay Design
2026-08-11
Dihydrotestosterone (DHT) is a precise androgen receptor perturbation tool for studying transcription, EGFR–ERBB2 signaling, and muscle phenotypes. This guide connects product handling with evidence-based assay decisions and insights from a recent prostate biology study.